Cargando…

Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study

BACKGROUND: Sepsis delays wound re-epithelialization. In this study we explored the effect of human sepsis sera as well as the effects of cytokines, growth factors and exosomes of sepsis sera treated normal fibroblasts (NF) on keratinocyte migration and proliferation in vitro. METHODS: Serum samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaurila, Henna, Koivukangas, Vesa, Koskela, Marjo, Gäddnäs, Fiia, Salo, Sirpa, Korvala, Johanna, Risteli, Maija, Karhu, Toni, Herzig, Karl-Heinz, Salo, Tuula, Ala-Kokko, Tero I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237124/
https://www.ncbi.nlm.nih.gov/pubmed/28086962
http://dx.doi.org/10.1186/s12967-016-1110-7
_version_ 1782495468004048896
author Jaurila, Henna
Koivukangas, Vesa
Koskela, Marjo
Gäddnäs, Fiia
Salo, Sirpa
Korvala, Johanna
Risteli, Maija
Karhu, Toni
Herzig, Karl-Heinz
Salo, Tuula
Ala-Kokko, Tero I.
author_facet Jaurila, Henna
Koivukangas, Vesa
Koskela, Marjo
Gäddnäs, Fiia
Salo, Sirpa
Korvala, Johanna
Risteli, Maija
Karhu, Toni
Herzig, Karl-Heinz
Salo, Tuula
Ala-Kokko, Tero I.
author_sort Jaurila, Henna
collection PubMed
description BACKGROUND: Sepsis delays wound re-epithelialization. In this study we explored the effect of human sepsis sera as well as the effects of cytokines, growth factors and exosomes of sepsis sera treated normal fibroblasts (NF) on keratinocyte migration and proliferation in vitro. METHODS: Serum samples were taken on days 1, 4, and 9 from 44 patients diagnosed with severe sepsis, and from 14 matching healthy controls. We evaluated the effects of sepsis serum with or without TNF-α, EGF, EGF receptor inhibitor or exosomes of sepsis sera treated NF on human keratinocyte (HaCaT) proliferation (BrdU assay), viability (MTT assay), and migration (horizontal wound healing model). Cytokine levels of sepsis and healthy sera were measured by multiplex assay. Comparisons between groups were carried out using SPSS statistics and P < 0.05 was considered significant. RESULTS: Severe-sepsis sera collected on days 1, 4, and 9 reduced keratinocyte proliferation by 6% (P = 0.005), 20% (P = 0.001), and 18% (P = 0.002), respectively, compared to control sera. Cell viability in cultures exposed to sepsis sera from days 4 and 9 was reduced by 38% (P = 0.01) and 58% (P < 0.001), respectively. Open-surface wounds exposed to sepsis sera from days 1 and 4 were larger than those exposed to sera from healthy controls (60 vs. 31%, P = 0.034 and 66 vs. 31%, P = 0.023, respectively). Exosomes of sepsis or healthy sera treated NF inhibited keratinocyte migration. We detected higher serum levels of cytokines TNF-α (5.7 vs. 0.7 pg/ml, P < 0.001), IL-6 (24.8 vs. 3.8 pg/ml, P < 0.001), IL-10 (30.0 vs. 11.9 pg/ml, P = 0.040), and VEGF (177.9 vs. 48.1 pg/ml, P = 0.018) in sepsis sera. Levels of EGF were significantly lower in sepsis sera than in that of healthy controls (6.5 vs. 115.6 pg/ml, P < 0.001). Sepsis serum supplemented with EGF 5 ng/ml and TNF-α in all concentrations improved keratinocyte migration. CONCLUSIONS: Keratinocyte viability, proliferation and migration were reduced in severe sepsis in vitro. Exosomes from NF added in healthy or sepsis serum media inhibited keratinocyte migration. Decreased levels of EGF in sepsis sera may partially explain the delay of wound healing with severe-sepsis patients. Increased levels of TNF-α in sepsis sera do not explain diminished keratinocyte migration.
format Online
Article
Text
id pubmed-5237124
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52371242017-01-18 Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study Jaurila, Henna Koivukangas, Vesa Koskela, Marjo Gäddnäs, Fiia Salo, Sirpa Korvala, Johanna Risteli, Maija Karhu, Toni Herzig, Karl-Heinz Salo, Tuula Ala-Kokko, Tero I. J Transl Med Research BACKGROUND: Sepsis delays wound re-epithelialization. In this study we explored the effect of human sepsis sera as well as the effects of cytokines, growth factors and exosomes of sepsis sera treated normal fibroblasts (NF) on keratinocyte migration and proliferation in vitro. METHODS: Serum samples were taken on days 1, 4, and 9 from 44 patients diagnosed with severe sepsis, and from 14 matching healthy controls. We evaluated the effects of sepsis serum with or without TNF-α, EGF, EGF receptor inhibitor or exosomes of sepsis sera treated NF on human keratinocyte (HaCaT) proliferation (BrdU assay), viability (MTT assay), and migration (horizontal wound healing model). Cytokine levels of sepsis and healthy sera were measured by multiplex assay. Comparisons between groups were carried out using SPSS statistics and P < 0.05 was considered significant. RESULTS: Severe-sepsis sera collected on days 1, 4, and 9 reduced keratinocyte proliferation by 6% (P = 0.005), 20% (P = 0.001), and 18% (P = 0.002), respectively, compared to control sera. Cell viability in cultures exposed to sepsis sera from days 4 and 9 was reduced by 38% (P = 0.01) and 58% (P < 0.001), respectively. Open-surface wounds exposed to sepsis sera from days 1 and 4 were larger than those exposed to sera from healthy controls (60 vs. 31%, P = 0.034 and 66 vs. 31%, P = 0.023, respectively). Exosomes of sepsis or healthy sera treated NF inhibited keratinocyte migration. We detected higher serum levels of cytokines TNF-α (5.7 vs. 0.7 pg/ml, P < 0.001), IL-6 (24.8 vs. 3.8 pg/ml, P < 0.001), IL-10 (30.0 vs. 11.9 pg/ml, P = 0.040), and VEGF (177.9 vs. 48.1 pg/ml, P = 0.018) in sepsis sera. Levels of EGF were significantly lower in sepsis sera than in that of healthy controls (6.5 vs. 115.6 pg/ml, P < 0.001). Sepsis serum supplemented with EGF 5 ng/ml and TNF-α in all concentrations improved keratinocyte migration. CONCLUSIONS: Keratinocyte viability, proliferation and migration were reduced in severe sepsis in vitro. Exosomes from NF added in healthy or sepsis serum media inhibited keratinocyte migration. Decreased levels of EGF in sepsis sera may partially explain the delay of wound healing with severe-sepsis patients. Increased levels of TNF-α in sepsis sera do not explain diminished keratinocyte migration. BioMed Central 2017-01-13 /pmc/articles/PMC5237124/ /pubmed/28086962 http://dx.doi.org/10.1186/s12967-016-1110-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jaurila, Henna
Koivukangas, Vesa
Koskela, Marjo
Gäddnäs, Fiia
Salo, Sirpa
Korvala, Johanna
Risteli, Maija
Karhu, Toni
Herzig, Karl-Heinz
Salo, Tuula
Ala-Kokko, Tero I.
Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study
title Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study
title_full Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study
title_fullStr Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study
title_full_unstemmed Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study
title_short Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study
title_sort inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237124/
https://www.ncbi.nlm.nih.gov/pubmed/28086962
http://dx.doi.org/10.1186/s12967-016-1110-7
work_keys_str_mv AT jaurilahenna inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT koivukangasvesa inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT koskelamarjo inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT gaddnasfiia inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT salosirpa inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT korvalajohanna inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT ristelimaija inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT karhutoni inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT herzigkarlheinz inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT salotuula inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy
AT alakokkoteroi inhibitoryeffectsofserumfromsepsispatientsonepithelialcellmigrationinvitroacasecontrolstudy